OpenAI’s board is locked in complex negotiations to become a for-profit company, struggling to determine the price of Microsoft’s stake in the start-up while holding talks to value its newly formed ...

The company is making a foray into scientific discovery with an AI built to help manufacture stem cells. A string of startups are racing to build models that can produce better and better software.